Definium Therapeutics
Price & Volume
Stats
See more52W Range | $8.58-$49.20 |
Market Cap | $5.6B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.47 |
News
See moreYahoo Finance • yesterday
Definium Therapeutics (DFTX) Redefines Depression & Anxiety Treatment
Yahoo Finance • 9 days ago
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva
Yahoo Finance • 16 days ago
Which Pharmaceuticals ETF Is Better, the iShares IHE or State Street XPH?
Yahoo Finance • 17 days ago
The Race to Commercialize the World’s Most Powerful Psychedelic
About
CEO | Mr. Robert Barrow |
Address | One World Trade Center, New York, NY, United States, 10007 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 105 |